Jane Street
TXG icon

Jane Street’s 10x Genomics TXG Stock Holding History

Jane Street’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.9M Buy
+752,999
New +$19.7M ﹤0.01% 1823
2026
Q1 		– Sell
-24,155
Closed -$483K – 13025
2025
Q4 		$394K Sell
24,155
-126,221
-84% -$1.91M ﹤0.01% 8222
2025
Q3 		$1.76M Buy
+150,376
New +$1.96M ﹤0.01% 5179
2025
Q2 		– Sell
-228,685
Closed -$2.08M – 10934
2025
Q1 		$2M Sell
228,685
-131,572
-37% -$1.66M ﹤0.01% 4353
2024
Q4 		$5.17M Buy
360,257
+203,049
+129% +$3.2M ﹤0.01% 2609
2024
Q3 		$3.55M Sell
157,208
-32,584
-17% -$674K ﹤0.01% 3429
2024
Q2 		$3.69M Buy
189,792
+174,938
+1,178% +$4.58M ﹤0.01% 3451
2024
Q1 		$557K Sell
14,854
-56,597
-79% -$2.49M ﹤0.01% 6468
2023
Q4 		$4M Buy
71,451
+50,548
+242% +$2.2M ﹤0.01% 3186
2023
Q3 		$862K Sell
20,903
-49,012
-70% -$2.55M ﹤0.01% 5413
2023
Q2 		$3.9M Buy
69,915
+8,604
+14% +$466K ﹤0.01% 3096
2023
Q1 		$3.42M Sell
61,311
-6,518
-10% -$304K ﹤0.01% 2967
2022
Q4 		$2.47M Buy
67,829
+42,816
+171% +$1.4M ﹤0.01% 3524
2022
Q3 		$712K Sell
25,013
-5,973
-19% -$228K ﹤0.01% 6036
2022
Q2 		$1.4M Buy
+30,986
New +$1.61M ﹤0.01% 4847
2022
Q1 		– Sell
-15,433
Closed -$1.35M – 11040
2021
Q4 		$2.3M Sell
15,433
-498
-3% -$76.3K ﹤0.01% 4205
2021
Q3 		$2.32M Sell
15,931
-21,700
-58% -$3.73M ﹤0.01% 4172
2021
Q2 		$7.37M Buy
37,631
+13,214
+54% +$2.39M ﹤0.01% 2084
2021
Q1 		$4.42M Sell
24,417
-5,161
-17% -$891K ﹤0.01% 2580
2020
Q4 		$4.19M Sell
29,578
-88,626
-75% -$12.9M ﹤0.01% 2347
2020
Q3 		$14.7M Buy
118,204
+115,656
+4,539% +$12.1M 0.01% 939
2020
Q2 		$228K Sell
2,548
-35,718
-93% -$2.78M ﹤0.01% 6204
2020
Q1 		$2.38M Buy
+38,266
New +$2.99M ﹤0.01% 1849
2019
Q4 		– Sell
-10,047
Closed -$506K – 5768
2019
Q3 		$506K Buy
+10,047
New +$556K ﹤0.01% 3530

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street's TXG Position: Q2 2026 in Review

Jane Street opened a new position in 10x Genomics (TXG) in Q2 2026: 752,999 shares worth $28.9M. The stake represents ﹤0.01% of the portfolio and ranks #1823 among its holdings. This is a return to the name: Jane Street previously reported a position in TXG as recently as Q4 2025.

Jane Street first reported a position in TXG in Q3 2019 and has held it in 24 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Jane Street held 752,999 shares of 10x Genomics worth $28.9M as of Q2 2026.
  • 10x Genomics was a new Jane Street position in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #1823 holding.
  • Jane Street first reported a position in 10x Genomics in Q3 2019 and has held it in 24 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.